asa glp 1 guidelines Holding GLP-1 Agonists Prior to Elective Procedures Perioperative Management of GLP-1 RAs

One of the vision disorders people taking Wegovy may experience is typically called non-arteritic anterior ischemic optic neuropathy (NAION), which involves restricted blood flow to the optic nerve

Patient-Friendly Timeline Retatrutide, CagriSema, and orforglipron are currently in Phase 3 testing

Abstract Background Pharmacologic therapies for heart failure with preserved ejection fraction (HFpEF) have shown limited efficacy, and the impact of GLP-1 receptor agonists (GLP-1 RAs) remains unclear

These combined effects result in improved hemoglobin A1c levels, significant weight reduction, and favorable changes in cardiovascular risk factors including blood pressure and lipid profiles, though cardiovascular outcomes benefits have not yet been established

Other than some fatigue it does curb appetite pretty well

Novel analogues and even dual-agonist/tri-agonist drugs in the pipeline may require further capacity in the next decade